Abstract
The rapid expansion of the oncology field has revealed new insights into cell death processes, with a particular emphasis on the role of ferroptosis. Characterized by iron dependency and the accumulation of lipid peroxides and iron within cells, ferroptosis stands out as a unique form of programmed cell demise. This in-depth analysis delves into the pivotal role of IGF2BP3, an RNA-binding protein, in the complex regulatory network of ferroptosis in cancerous cells. By exerting post-transcriptional control over genes associated with iron equilibrium, IGF2BP3 is demonstrated to manage cellular iron concentrations and reactive oxygen species (ROS) equilibrium, thus affecting the destiny of the cell. The correlation between aberrant IGF2BP3 expression and increased aggressiveness, metastatic capacity, and poor prognosis in various cancers is further clarified. The potential of IGF2BP3 as a biomarker for prognosis and a therapeutic agent to enhance cancer cells' vulnerability to ferroptosis is also examined, heralding new strategies in cancer treatment.